In the BioHarmony Drug Report Database

"Preview" Icon

Bepotastine besilate

Bepreve (bepotastine besylate) is a small molecule pharmaceutical. Bepotastine besylate was first approved as Bepreve on 2009-09-08. Bepreve’s patent is valid until 2025-01-13 (FDA).

 

Trade Name

 

Bepreve
 

Common Name

 

bepotastine besylate
 

ChEMBL ID

 

CHEMBL1201759
 

Indication

 

 

Drug Class

 

Antihistaminics (histamine-H1 receptor antagonists)

Image (chem structure or protein)

Bepotastine besilate structure rendering